Sorted By:

Relevance


PhRMA Applauds Passage of Korea-U.S. Free Trade Agreement

PhRMA  |  Press Release

(October 13, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani released the following statement on the passage of the Korea-U.S.
https://www.phrma.org/press-release/phrma-applauds-passage-of-korea-u-s-free-trade-agreement

Antibiotics Conference Addresses Lack of New Drugs to Fight Deadly Superbugs

PhRMA  |  Press Release

www.pewtrusts.org/health About IDSAThe Infectious Diseases Society of America (IDSA) is an organization of physicians, scientists, and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, patient care, prevention, and public health.
https://www.phrma.org/press-release/antibiotics-conference-addresses-lack-of-new-drugs-to-fight-deadly-superbugs

PhRMA Statement on National Governors Association’s Prescription Drug Abuse Reduction Policy Academy

PhRMA  |  Press Release

Find PhRMA Online: Website – http://www.phrma.org facebook – www.facebook.com/PhRMA Blog – www.phrma.org/catalyst Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress YouTube – www.youtube.com/PhRMApress For information on how innovative medicines save lives, visit: http://www.innovation.org For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org
https://www.phrma.org/press-release/phrma-statement-on-national-governors-association-s-prescription-drug-abuse-reduction-policy-academy

New JAMA Study Highlights Continued Success of Medicare Part D

PhRMA  |  Press Release

  A recent paper from the Battelle Technology Partnership Practice estimated that a $20 billion per year reduction in biopharmaceutical sector revenue would result in 260,000 job losses across the U.S. economy.  
https://www.phrma.org/press-release/new-jama-study-highlights-continued-success-of-medicare-part-d

America’s Biopharmaceutical Companies’ Commitment to Research Remains Strong Despite Challenges

PhRMA  |  Press Release

According to a report released by PhRMA earlier this year, more than 5,400 medicines are in development globally, representing future opportunities for new, cutting-edge medicines to improve patient care and bring value to the U.S. health care system.
https://www.phrma.org/press-release/america-s-biopharmaceutical-companies-commitment-to-research-remains-strong-despite-challenges

VIDEO: PhRMA CEO discusses industry response to opioid crisis on Mornings with Maria

PhRMA  |  Blog Post

Most recently, PhRMA announced its support for policies limiting the supply of opioids to seven days for acute pain treatment.
http://catalyst.phrma.org/video-phrma-ceo-discusses-industry-response-to-opioid-crisis-on-mornings-with-maria

Nearly 200 Medicines in Development for Arthritis and Related Disorders, The Nation’s Most Common Cause of Disability

PhRMA  |  Press Release

According to the Arthritis Foundation, a landmark government study released in 2008 suggests that nearly one in two Americans (45%) will develop painful knee osteoarthritis over their lifetime.
https://www.phrma.org/press-release/nearly-200-medicines-in-development-for-arthritis-and-related-disorders-the-nation-s-most-common-cause-of-disability

PhRMA Names Bob Filippone Senior Vice President, Federal Advocacy

PhRMA  |  Press Release

Washington, D.C. (March 10, 2011) — The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Robert J. Filippone, PhD, has been named Senior Vice President of Federal Advocacy, effective immediately. Dr. Filippone will report to Executive Vice Preside...
https://www.phrma.org/press-release/phrma-names-bob-filippone-senior-vice-president-federal-advocacy

PhRMA Statement Regarding Prescription Drug User Fee Act Reauthorization

PhRMA  |  Press Release

Washington, D.C. (May 24, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:   “Today’s Senate vote passing the Food and Drug Administration Safety and Innovation Act demon...
https://www.phrma.org/press-release/phrma-statement-regarding-prescription-drug-user-fee-act-reauthorization1

Survey Shows Americans Remain Positive About Their Own Health, Less Optimistic About ‘Average American’

PhRMA  |  Press Release

Washington, D.C. (August 13, 2014) — The majority of Americans report they have had a good year when it comes to their personal health and are paying more attention to their health compared to just a few years ago, according to .phrma.org/sites/default/files/pd...
https://www.phrma.org/press-release/survey-shows-americans-remain-positive-about-their-own-health-less-optimistic-about-average-american

PhRMA Statement on Withdrawal of Patent Legislation from Senate Judiciary Committee Agenda

PhRMA  |  Press Release

Washington, D.C. (May 21, 2014) — Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President and General Counsel Mit Spears issued the following statement on the patent legislation pending in the U.S. Senate: "PhRMA appreciates the efforts of Sen...
https://www.phrma.org/press-release/phrma-statement-on-withdrawal-of-patent-legislation-from-senate-judiciary-committee-agenda

RxOpen Activated to Report on Status of Pharmacies in Oklahoma

PhRMA  |  Press Release

WASHINGTON, D.C. (May 20, 2013) – Rx Response  elevated its status to Alert and has activated Rx Open in the aftermath of yesterday’s deadly tornado in Moore, Oklahoma. (www.RxResponse.org).  Rx Response and Rx Open are initiatives of Amer...
https://www.phrma.org/press-release/rxopen-activated-to-report-on-status-of-pharmacies-in-oklahoma

Over 900 Biotechnology Medicines in Development, Targeting More than 100 Diseases

PhRMA  |  Press Release

Washington, D.C. (September 14, 2011) — America's biopharmaceutical research companies have 901 biotechnology medicines and vaccines in development to target more than 100 debilitating and life-threatening diseases, such as cancer, arthritis and diabetes, according to a ...
https://www.phrma.org/press-release/over-900-biotechnology-medicines-in-development-targeting-more-than-100-diseases

Rx Response Activates Open Pharmacy Reporting Tool in Wake of Hurricane Irene

PhRMA  |  Press Release

WASHINGTON, D.C.  --  Rx Response has activated its unique Pharmacy Reporting Status Tool to aid storm managers and people in communities affected by Hurricane Irene.  The Pharmacy Status Re...
https://www.phrma.org/press-release/rx-response-activates-open-pharmacy-reporting-tool-in-wake-of-hurricane-irene

PhRMA Statement on Google Settlement with US Department of Justice

PhRMA  |  Press Release

Washington, D.C. (August 24, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President Karl Uhlendorf issued the following statement today regarding .google.com/"...
https://www.phrma.org/press-release/phrma-statement-on-google-settlement-with-us-department-of-justice

New Survey Identifies America’s Health Priorities: Obesity, Cancer Cures, Senior Care

PhRMA  |  Press Release

WASHINGTON, D.C. (August 2, 2013) – A new survey commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA) shows 86 percent of Americans believe developing cures for more forms of cancer should be one of the top nati...
https://www.phrma.org/press-release/new-survey-identifies-america-s-health-priorities-obesity-cancer-cures-senior-care

PhRMA Statement on Recent Comments to Drug Enforcement Administration

PhRMA  |  Press Release

Washington, D.C. (January 20, 2011) — The Pharmaceutical Research and Manufacturers of America (PhRMA) recently had the opportunity to provide comments to the Drug Enforcement Administration (DEA) regarding the development of procedures for the surrender of unwanted controlled su...
https://www.phrma.org/press-release/phrma-statement-on-recent-comments-to-drug-enforcement-administration

PhRMA Statement on Medicare Drug Savings Act of 2013

PhRMA  |  Press Release

WASHINGTON, D.C. (April 16, 2013) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett today issued the following statement: "Several members of Congress today echoed President Obama’s recycling of a flawed p...
https://www.phrma.org/press-release/phrma-statement-on-medicare-drug-savings-act-of-2013

PhRMA Names Charles Clapton, Senior Vice President, Federal Advocacy

PhRMA  |  Press Release

Washington, DC (February 25, 2014) – The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the appointment of Charles “Chuck” Clapton to the position of Senior Vice President, Federal Advocacy, effective March 17, 2014.   In this capacity, Clapton will be respons...
https://www.phrma.org/press-release/phrma-names-charles-clapton-senior-vice-president-federal-advocacy

PhRMA Applauds Bipartisan Senate Support for Strong Intellectual Property Protections in the Trans-Pacific Partnership Agreement

PhRMA  |  Press Release

(May 19, 2011) – Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President International Jay Taylor released the following statement today: “The 28 Senators who signed the bipartisan letter to President Obama should be commended for their leadership in pushing for strong intellectual property protection (IP) in the Trans-Pacific Partnership Agreement (TPP).
https://www.phrma.org/press-release/phrma-applauds-bipartisan-senate-support-for-strong-intellectual-property-protections-in-the-trans-pacific-partnership-agreement

Panel Discussion and New Report Highlight Benefit of Vermont Clinical Trials for Patients, State Economy

PhRMA  |  Press Release

(December 12, 2013) – Working with Vermont research institutions, including the University of Vermont and Fletcher Allen Health Care in Burlington, the nation's biopharmaceutical research companies have conducted 566 clinical trials of new medicines since 1999, according to a new report released today and highlighted at a panel discussion in Burlington.
https://www.phrma.org/press-release/panel-discussion-and-new-report-highlight-benefit-of-vermont-clinical-trials-for-patients-state-economy

PhRMA Applauds 2016 We Work For Health Champion Award Winners

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-applauds-2016-we-work-for-health-champion-award-winners

Research Supported by Biopharmaceutical Companies Boosts Montana Economy, Benefits Local Patients

PhRMA  |  Press Release

The report – “Research in Your Backyard: Pharmaceutical Clinical Trials in Montana” – was released today at a panel discussion in Billings sponsored by the Montana Healthcare Access Network, Montana BioScience Alliance and PhRMA. 
https://www.phrma.org/press-release/research-supported-by-biopharmaceutical-companies-boosts-montana-economy-benefits-local-patients

PhRMA and Epilepsy Foundation Report More Than 400 Medicines in Development to Treat Neurological Disorders

PhRMA  |  Press Release

For additional information, please visit www.epilepsy.com.
https://www.phrma.org/press-release/phrma-and-epilepsy-foundation-report-more-than-400-medicines-in-development-to-treat-neurological-disorders

PhRMA and The ALS Association Report More Than 560 Medicines in Development for Rare Diseases

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-and-the-als-association-report-more-than-560-medicines-in-development-for-rare-diseases

You have reviewed the first 450 results out of 877. Each page contains 25 results. You're on page 18.

prev 13 14 15 16 17 18 next